Karin Jooss - Feb 1, 2024 Form 4 Insider Report for Gritstone bio, Inc. (GRTS)

Role
EVP, Head of Research and Development
Signature
/s/ Vassiliki Economides, Attorney-in-Fact for Karin Jooss
Stock symbol
GRTS
Transactions as of
Feb 1, 2024
Transactions value $
$0
Form type
4
Date filed
2/5/2024, 07:08 PM
Previous filing
Jun 7, 2023
Next filing
May 17, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GRTS Common Stock Award $0 +40K +6.57% $0.00 649K Feb 1, 2024 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GRTS Stock Option (Right to Buy) Award $0 +235K $0.00 235K Feb 1, 2024 Common Stock 235K $2.46 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents Restricted Stock Units ("RSUs") of which 1/2 vests on the first anniversary of the grant date, with the remainder of grant vesting on the second anniversary of the grant date, subject to the continued service of the Reporting Person on each vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock.
F2 Includes 271,467 RSUs which are subject to vesting.
F3 The option vests as to 1/24th of the total grant monthly beginning February 1, 2024 until such time as the option is 100% vested, subject to the continued service of the Reporting Person on each vesting date.

Remarks:

EVP, Head of Research and Development